Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview

Heron Therapeutics

07/08/2026 18:00

Heron Therapeutics Inc HRTX.OQ HRTX.O is expected to  show a rise in quarterly revenue when it reports  results on August 10 for the period ending June 30 2026
The Cary North Carolina-based  company is expected to report a 13.4% increase in revenue to $42.2 million from $37.2 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Heron Therapeutics Inc is for earnings of 1 cent per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Heron Therapeutics Inc is $2.50, about 401% above its last closing price of $0.50
This summary was machine generated August 7 at 17:00 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)